Correlation between cognitive effects and level of acetylcholinesterase inhibition in a trial of rivastigmine in Alzheimer patients

被引：0
|
作者：
Cutler, NR
Veroff, AE
Anand, R
Hartman, R
Mancione, L
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A173 / A173
页数：1
相关论文
共 50 条
  • [21] Effects of Rivastigmine Transdermal Patch on Cognitive Ability in Patients with Mild-to-Moderately Severe Alzheimer's Disease
    Grossberg, George T.
    Schmitt, Frederick A.
    Olin, Jason T.
    Meng, Xiangyi
    NEUROLOGY, 2010, 74 (09) : A270 - A271
  • [22] Acetyl- and butyryl-cholinesterase inhibition by rivastigmine in cerebrospinal fluid of patients with Alzheimer's disease correlates with cognitive benefit
    Giacobini, E
    Spiegel, R
    Enz, A
    Sramek, J
    Cutler, N
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S73 - S73
  • [23] Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia
    Lenzi, A
    Maltinti, E
    Poggi, E
    Fabrizio, L
    Coli, E
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (06) : 317 - 321
  • [24] Effects of rivastigmine on cognitive function in patients with traumatic brain injury
    Silver, J. M.
    Koumaras, B.
    Chen, M.
    Mirski, D.
    Potkin, S. G.
    Reyes, P.
    Warden, D.
    Harvey, P. D.
    Arciniegas, D.
    Katz, D. I.
    Gunay, I.
    NEUROLOGY, 2006, 67 (05) : 748 - 755
  • [25] Effects of rivastigmine on cognitive function in patients with traumatic brain injury
    Noble, James M.
    Hauser, W. Allen
    NEUROLOGY, 2007, 68 (20) : 1749 - 1749
  • [26] A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease
    D'Onofrio, Grazia
    Sancarlo, Daniele
    Addante, Filomena
    Ciccone, Filomena
    Cascavilla, Leandro
    Paris, Francesco
    Elia, Anna Chiara
    Nuzzaci, Claudia
    Picoco, Michele
    Greco, Antonio
    Panza, Francesco
    Pilotto, Alberto
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (09) : 965 - 975
  • [27] Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease
    Farlow, Martin R.
    Cummings, Jeffrey L.
    Olin, Jason T.
    Meng, Xiangyi
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (04): : 347 - 352
  • [28] Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease
    Ohta, Yasuyuki
    Darwish, Mohamed
    Hishikawa, Nozomi
    Yamashita, Toru
    Sato, Kota
    Takemoto, Mami
    Abe, Koji
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (11) : 1843 - 1848
  • [29] Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years
    Small, GW
    Kaufer, D
    Mendiondo, MS
    Quarg, P
    Spiegel, R
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (04) : 473 - 477
  • [30] Effects of Rivastigmine Transdermal Patch on Cognitive Function and Body Weight: An Observational, Retrospective Study in Japanese Patients With Alzheimer Disease
    Kaneda, Yasuhiro
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S505 - S506
12345